AzurRx BioPharma Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
219.90
638.50
1,773.50
573.50
1,114.30
Total Accounts Receivable
428.80
1,074.90
961.00
1,104.10
3,172.70
Other Current Assets
14.80
354.00
229.40
275.00
513
Total Current Assets
663.50
2,067.40
2,964.00
1,952.60
4,800
Net Property, Plant & Equipment
211.70
176.30
151.60
134.00
128.90
Long-Term Note Receivable
-
-
-
1,071.10
-
Intangible Assets
5,680.30
4,416.40
3,603.60
3,362.20
2,495.30
Other Assets
20.30
25.60
34.70
30.90
45.20
Total Assets
6,575.80
6,685.70
6,753.80
6,550.70
7,469.40
ST Debt & Current Portion LT Debt
1,052.30
6,577.40
155.20
416.50
Accounts Payable
-
-
-
1,573.10
Other Current Liabilities
1,378.60
2,238.10
2,185.70
489.40
Total Current Liabilities
2,430.90
8,815.50
2,340.80
2,479.10
Provision for Risks & Charges
1,500.00
1,500.00
1,200.00
-
Other Liabilities
-
-
-
1,340.00
Total Liabilities
3,930.90
10,315.50
3,540.80
3,819.10
Common Equity (Total)
2,255.10
7,108.80
3,213.00
2,731.70
Total Shareholders' Equity
2,644.90
3,629.80
3,213.00
2,731.70
Total Equity
2,644.90
3,629.80
3,213.00
2,731.70
Liabilities & Shareholders' Equity
6,575.80
6,685.70
6,753.80
6,550.70
Preferred Stock (Carrying Value)
4,900.00
3,479.00
-
-
About AzurRx BioPharma
View Profile
